Company Now Materially Debt Free with Over $13M in Cash
TORONTO, Sept. 17, 2024 /CNW/ - MediPharm Labs Corp. ("MediPharm" or the "Company") (TSX: LABS), a specialized, research-driven pharmaceutical company focused on cannabis-based health products, is pleased to announce that it has paid off the entire remaining convertible debt amount of $2.1 million, leaving the Company materially debt-free.
Read more at newswire.ca